Literature DB >> 21247286

The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: indications, complications, and outcomes in 5803 patients.

Jean de la Rosette1, Dean Assimos, Mahesh Desai, Jorge Gutierrez, James Lingeman, Roberto Scarpa, Ahmet Tefekli.   

Abstract

PURPOSE: To assess the current indications, perioperative morbidity, and stone-free outcomes for percutaneous nephrolithotomy (PCNL) worldwide. PATIENTS AND METHODS: The Clinical Research Office of the Endourological Society (CROES) collected prospective data for consecutive patients who were treated with PCNL at centers around the world for 1 year. PCNL was performed according to study protocol and local clinical practice guidelines. Stone load and location were recorded, and postoperative complications were graded according to the modified Clavien grading system.
RESULTS: Between November 2007 and December 2009, 5803 patients were treated at 96 centers in Europe, Asia, North America, South America, and Australia. Staghorn calculus was present in 1466 (27.5%) patients, and 940, 956, and 2603 patients had stones in the upper, interpolar, and lower pole calices, respectively. The majority of procedures (85.5%) were uneventful. Major procedure-related complications included significant bleeding (7.8%), renal pelvis perforation (3.4%), and hydrothorax (1.8%). Blood transfusion was administered in 328 (5.7%) patients, and fever >38.5°C occurred in 10.5% of patients. The distribution of scores in modified Clavien grades was: No complication (79.5%), I (11.1%), II (5.3%), IIIa (2.3%), IIIb (1.3%), IVa (0.3%), IVb (0.2%), or V (0.03%). At follow-up. the 30-day stone-free rate was 75.7%, and 84.5% of patients did not need additional treatment.
CONCLUSION: With a high success rate and a low major complication rate, PCNL is an effective and safe technique overall for minimally invasive removal of kidney stones.

Entities:  

Mesh:

Year:  2011        PMID: 21247286     DOI: 10.1089/end.2010.0424

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  180 in total

1.  Laser-guided percutaneous kidney access with the Uro Dyna-CT: first experience of three-dimensional puncture planning with an ex vivo model.

Authors:  M Ritter; M-C Rassweiler; A Häcker; M S Michel
Journal:  World J Urol       Date:  2012-03-04       Impact factor: 4.226

Review 2.  [Benign prostatic hyperplasia and urolithiasis].

Authors:  T Knoll; R Hofmann; K Höfner
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

3.  Is there a place for virtual reality simulators in assessment of competency in percutaneous renal access?

Authors:  Yasser A Noureldin; Nader Fahmy; Maurice Anidjar; Sero Andonian
Journal:  World J Urol       Date:  2015-08-05       Impact factor: 4.226

4.  Iatrogenic hepatic subcapsular biloma following PCNL: Diagnosis and management.

Authors:  Mohamed Omar; Manoj Monga; Mark Noble
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

5.  External validation of the S.T.O.N.E. nephrolithometry scoring system.

Authors:  Yasser A Noureldin; Mohamed A Elkoushy; Sero Andonian
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

6.  Percutaneous nephrolithotomy for isolated calyceal stones: How important is the stone location?

Authors:  Faruk Özgör; Onur Küçüktopcu; Abdulmuttalip Şimşek; Ömer Sarılar; Murat Binbay; Gökhan Gürbüz
Journal:  Turk J Urol       Date:  2015-12

7.  Percutaneous nephrolithotomy for staghorn stones: Which nomogram can better predict postoperative outcomes?

Authors:  Stavros Sfoungaristos; Ofer N Gofrit; Dov Pode; Ezekiel H Landau; Mordechai Duvdevani
Journal:  World J Urol       Date:  2015-12-11       Impact factor: 4.226

Review 8.  Risk factors for sepsis after percutaneous renal stone surgery.

Authors:  Evgeniy I Kreydin; Brian H Eisner
Journal:  Nat Rev Urol       Date:  2013-09-03       Impact factor: 14.432

9.  Age-related prevalence of diabetes mellitus, cardiovascular disease and anticoagulation therapy use in a urolithiasis population and their effect on outcomes: the Clinical Research Office of the Endourological Society Ureteroscopy Global Study.

Authors:  F Pedro J Daels; Andrius Gaizauskas; Jorge Rioja; Anil K Varshney; Erkan Erkan; Yasar Ozgok; Michael Melekos; Jean J M C H de la Rosette
Journal:  World J Urol       Date:  2014-08-26       Impact factor: 4.226

10.  Rationale and Design of the Registry for Stones of the Kidney and Ureter (ReSKU): A Prospective Observational Registry to Study the Natural History of Urolithiasis Patients.

Authors:  Helena C Chang; David T Tzou; Manint Usawachintachit; Brian D Duty; Ryan S Hsi; Jonathan D Harper; Mathew D Sorensen; Marshall L Stoller; Roger L Sur; Thomas Chi
Journal:  J Endourol       Date:  2016-11-01       Impact factor: 2.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.